Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).
about
Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancersTransoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neckTransoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer.Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.Long-term outcome and patterns of failure in patients with advanced head and neck cancer.Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes.Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer.Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome?Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.IMRT for head and neck cancer: reducing xerostomia and dysphagia.A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinomaVolumetric stratification of cT4 stage head and neck cancer.Concurrent chemotherapy and radiotherapy for head and neck cancer.A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment.Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosis.Human papillomavirus and oropharynx cancer: biology, detection and clinical implications.Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine.Organ-sparing radiation therapy for head and neck cancer.Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.Infrahyoid flap in oropharyngeal reconstruction following carcinoma resection: A study of 6 patients and literature review.Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaLocally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer.Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.Trial Watch: Anticancer radioimmunotherapy.Trial Watch: Radioimmunotherapy for oncological indications.Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.Longitudinal and long-term effects of radiotherapy on swallowing function after tongue reconstruction.
P2860
Q26866157-E9CACCC7-E10A-4EC9-95E8-864D97CE6661Q33477468-F6EBB097-5C8C-48A3-9E45-87D0438821F3Q33667302-C92C8329-5F93-42B5-847A-33B2709AF3A6Q33809636-E30D6D02-39E2-4631-B192-3757140C862DQ33987317-C3AB4773-37B1-4A32-82B1-EF1CE49ABBE1Q34007100-10F4BD22-7C1F-46E1-9DEC-D6CE1C93C556Q34394972-7B5E7E91-A20C-44A1-8C0A-1FDA31BF0EC2Q35084265-AA5E4D5F-054F-4B23-B916-DDEC30273EE9Q35875691-4CDB9869-1E60-4D22-9204-A13236C04CFFQ35930366-EEA34224-3414-4C31-9F85-0586C85A1FECQ36111256-E48DE25C-765B-4E33-9316-77ADFB8B467EQ36324844-227C33EA-2690-4E89-9AAD-9689CCA08756Q36621257-DAC22417-A8E8-40CC-98D1-79CADAACC1B1Q37187245-210F9568-8C23-4823-8F0F-CBFF8EBB3EC1Q37225655-C510F04D-196F-4071-A282-CF10687A910FQ37301384-D4AEEDB5-607C-4B61-86E8-22226612DA6AQ37411168-656A911B-31D3-413C-823F-E81F8F144A7BQ37566349-66C1140D-6842-44E0-931E-C3EB568E7646Q37649625-BC7EF324-988A-4C83-97D9-EE848E678523Q37776459-96AFE822-18E5-49FD-AAD3-04C6B8DB0374Q37870017-046C294E-5945-4263-9E18-D60449186151Q37905536-08F74D5C-355B-437F-B1C9-F41EC1720434Q38074364-E57809CB-0F95-4719-A1F9-4328612C1354Q38257116-94041099-65EC-4A34-8237-3D5AF71753A0Q38819643-0696DA7E-6135-4F50-9F2F-DCE08C27729CQ38924379-6664917F-77F4-4B35-AF38-3B088B6E5AC8Q41514384-EFFEF513-38CF-4E57-A323-3640A740AEE3Q41858833-B801E169-D1B0-4C48-B71A-4F3D8A752C02Q42739703-ADAE5B9F-AF86-4EC4-B39F-CA30C44343A2Q42847992-6DBAAA83-511F-41E4-8CDE-FEB4D6BB2C55Q43104064-26F6BE33-7286-4FCD-8C3C-E9D72D85BEDEQ43597863-B2B30F47-57C7-4562-8E79-E2702728B470Q43955392-CEC3D86D-8D7A-4AFB-8B7B-7A9C40611826Q47633813-D4F504D8-46C1-47EC-BE8A-070614104709Q51075396-F2C8BE4B-F8DC-479D-B7DC-81595D6DD270Q51196826-FB4AC852-4CEF-43FD-A0A7-FE143CE750FE
P2860
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Long-term results of concomita ...... y oncology group (RTOG 99-14).
@en
type
label
Long-term results of concomita ...... y oncology group (RTOG 99-14).
@en
prefLabel
Long-term results of concomita ...... y oncology group (RTOG 99-14).
@en
P2093
P2860
P1476
Long-term results of concomita ...... y oncology group (RTOG 99-14).
@en
P2093
Adam S Garden
Andy Trotti
Arlene Forastiere
Christopher U Jones
Jonathan D Cheng
Jonathan Harris
K Kian Ang
Luis Carrascosa
Randal S Weber
Sharon S Spencer
P2860
P304
P356
10.1016/J.IJROBP.2008.04.006
P407
P577
2008-08-01T00:00:00Z